Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas

References

• Stiller CA, Trama A, Serraino D, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 1990;49(684–695):2013.
   Google Scholar
• Siegel RL, Miller KD: Cancer statistics, 2020. 70: 7–30
   Google Scholar
• Vincenzi B, Frezza AM, Santini D, et al. New therapies in soft tissue sarcoma. Expert Opin Emerg Drugs. 2010;15:237–248.
   PubMed Web of Science ®Google Scholar
• Casali PG, Abecassis N, Aro HT, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv268–iv269.
   PubMed Web of Science ®Google Scholar
• Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248–262.
   PubMed Web of Science ®Google Scholar
• Kim JW, Nam KH, Ahn SH, et al. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer. 2016;19:42–52.
   PubMed Web of Science ®Google Scholar
• Nathenson MJ, Conley AP, Sausville E. Immunotherapy: A new (and old) approach to treatment of soft tissue and bone sarcomas. Oncologist. 2018;23:71–83.
   PubMed Web of Science ®Google Scholar
• D’Angelo SP, Shoushtari AN, Agaram NP, et al. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Hum Pathol. 2015;46:357–365.
   PubMed Web of Science ®Google Scholar
• Kim JR, Moon YJ, Kwon KS, et al. Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas. PloS One. 2013;8:e82870.
   PubMed Web of Science ®Google Scholar
• Chen YP, Zhang Y, Lv JW, et al. Genomic analysis of tumor microenvironment immune types across 14 solid cancer types: immunotherapeutic implications. Theranostics. 2017;7:3585–3594.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Hong M, Chen X, et al. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. BMC Med Genomics. 2020;13:57.
   PubMed Web of Science ®Google Scholar
• Jia D, Li S, Li D, et al. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging (Albany NY). 2018;10:592–605.
   PubMedGoogle Scholar
• Yan H, Qu J, Cao W, et al.: Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. 68: 1971–1978, 2019.
   Google Scholar
• Hu C, Chen B, Huang Z, et al. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients. J Transl Med. 2020;18:337.
   PubMed Web of Science ®Google Scholar
• Gu HY, Zhang C, Guo J, et al. Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma. Aging (Albany NY). 2020;12:3807–3827.
   PubMedGoogle Scholar
• Gu HY, Lin LL, Zhang C, et al. The potential of five immune-related prognostic genes to predict survival and response to immune checkpoint inhibitors for soft tissue sarcomas based on multi-omic study. Front Oncol. 2020;10:1317.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Xie C, Chen B, Wu B, et al. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis. Biomed Pharmacother. 2018;97:1645–1653.
   PubMed Web of Science ®Google Scholar
• Huang R, Meng T, Chen R, et al. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma. Aging (Albany NY). 2019;11:10116–10143.
   PubMedGoogle Scholar
• Zhu Z, Jin Z, Zhang H, et al. Integrative clustering reveals a novel subtype of soft tissue sarcoma with poor prognosis. Front Genet. 2020;11:69.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Hong W, Yuan H, Gu Y, et al.: Immune-related prognosis biomarkers associated with osteosarcoma microenvironment. 20: 83, 2020.
   Google Scholar
• Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321–330.
   PubMed Web of Science ®Google Scholar
• Blattman JN. Greenberg PD: cancer immunotherapy: a treatment for the masses. Science (New York, NY). 2004;305:200–205.
   Google Scholar
• Wan G, Zhaorigetu S, Liu Z, et al. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem. 2008;283:21540–21549.
   PubMed Web of Science ®Google Scholar
• Zhaorigetu S, Wan G, Kaini R, et al. ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death. Autophagy. 2008;4:1079–1082.
   PubMed Web of Science ®Google Scholar
• Jian L, Yang G: Identification of key genes involved in diabetic peripheral neuropathy progression and associated with pancreatic cancer. 13: 463–476, 2020.
   Google Scholar
• Sharpnack MF, Chen B, Aran D, et al. Global transcriptome analysis of RNA abundance regulation by ADAR in lung adenocarcinoma. EBioMedicine. 2018;27:167–175.
   PubMed Web of Science ®Google Scholar
• Chidiac M, Fayyad-Kazan M, Daher J, et al. ApolipoproteinL1 is expressed in papillary thyroid carcinomas. Pathol Res Pract. 2016;212:631–635.
   PubMed Web of Science ®Google Scholar
• Timpl R, Sasaki T, Kostka G, et al. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4:479–489.
   PubMed Web of Science ®Google Scholar
• Seeliger H, Camaj P, Ischenko I, et al. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res. 2009;7:189–198.
   PubMed Web of Science ®Google Scholar
• Wang Z, Cao CJ, Huang LL, et al. EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway. Oncotarget. 2015;6:14191–14208.
   PubMedGoogle Scholar
• Sunakawa Y, Yang D, Cao S, et al. Immune-related genes to dominate neutrophil-lymphocyte ratio (NLR) associated with survival of cetuximab treatment in metastatic colorectal cancer. Clin Colorectal Cancer. 2018;17:e741–e749.
   PubMed Web of Science ®Google Scholar
• Guo C, Li Z. Bioinformatics analysis of key genes and pathways associated with thrombosis in essential thrombocythemia. Med Sci Monit. 2019;25:9262–9271.
   PubMed Web of Science ®Google Scholar
• Roy A, Ramalinga M, Kim OJ, et al. Multiple roles of RARRES1 in prostate cancer: autophagy induction and angiogenesis inhibition. PloS One. 2017;12:e0180344.
   PubMed Web of Science ®Google Scholar
• Shyu RY, Wang CH, Wu CC, et al. Tazarotene-induced gene 1 enhanced cervical cell autophagy through transmembrane protein 192. Mol Cells. 2016;39:877–887.
   PubMed Web of Science ®Google Scholar
• Wang D, He MQ, Fan DQ. RARRES1 is a novel immune-related biomarker in GBM. Am J Transl Res. 2019;11:5655–5663.
   PubMed Web of Science ®Google Scholar
• Sarma V, Wolf FW, Marks RM, et al. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol (Baltimore, Md). 1950;148(3302–3312):1992.
   Google Scholar
• Hase K, Kimura S, Takatsu H, et al. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nat Cell Biol. 2009;11:1427–1432.
   PubMed Web of Science ®Google Scholar
• Wolf FW, Sarma V, Seldin M, et al. B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J Biol Chem. 1994;269:3633–3640.
   PubMed Web of Science ®Google Scholar
• Jia L, Shi Y, Wen Y, et al.: The roles of TNFAIP2 in cancers and infectious diseases. 22: 5188–5195, 2018.
   Google Scholar